Highlights
1 patent
About
One-step Urea Breath Test
Exalenz Bioscience develops and commercializes systems that extract vital information for diagnostics from subtle changes in patients' exhaled breath using the company's BreathID technology platform. The company's proprietary core technology enables medical specialists to easily identify and manage specific digestive and liver conditions while ensuring both clinical precision and patient comfort. The BreathID Hp is a clinically proven, easy, and accurate single-step urea breath test for diagnosing and monitoring H. pylori infection in adults.
Identity
| Name | Exalenz Bioscience |
|---|---|
| Slug | exalenz-bioscience |
| Type / kind | startup |
| Crunchbase ID | exalenz-bioscience |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6u28gJDA |
Status
| Status | inactive |
|---|---|
| Status reason | Acquired (Inactive) by Meridian Bioscience on May 2020 - closed due to acquisition |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Modi'in-Maccabim-Re'ut |
| HQ address | Ha-Ma'ayan St 4, Modi'in-Maccabim-Re'ut, Israel |
Web & social
| https://www.linkedin.com/company/204415 | |
| https://www.facebook.com/Breathid | |
| YouTube | https://www.youtube.com/channel/UCScxGUH5Ii4stSAvmyCN9hQ |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesMedical Monitors
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratories
Business models
B2B
Tags
bioconvergencegastroenterologydiagnosticsreal-timebacteriaulcersmedical-technologiesnon-invasivelaboratoriesdoctorsclinicshealthcare-providers
Funding
| Total raised | $10.7M |
|---|---|
| Current stage | Acquired |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}